Pharmasyntez JSC

SIBUR and the biopharmaceutical company Pharmasyntez have agreed to jointly develop and supply synthetic materials for the new production facility for hemodialysis and peritoneal dialysis consumables and equipment, which is scheduled to be commissioned in Kaluga Oblast in 2025.   Against the backdrop of the withdrawal of one of the largest suppliers of dialysate from the Russian market, Pharmasyntez and SIBUR have developed solutions in the shortest possible time to maintain technological sovereignty and further develop the Russian pharmaceutical industry. SIBUR will supply polymer materials such as polypropylene and polyethylene for Pharmasyntez's new production.   In addition, for the production of dialyzer housings, SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization, an important step in creating domestically produced world-class medical products. The development and testing of the formulation is expected to be completed in 2025.   Pharmasyntez has successfully used the medical grade polyethylene MG 013 developed by SIBUR for packaging infusion solutions by the blow-fill-seal (BFS) method as part of the company's import substitution strategy at its Irkutsk plant.   Anton Prozumentov, Director of Sibur's Pharmaceuticals Department, said: "Development of the Russian pharmaceutical industry is one of the important areas of ensuring the country's technological independence. We actively support efforts to replace imports, especially in strategically important sectors such as medicines. SIBUR attaches great importance to the development and implementation of high-tech solutions to create high-quality, reasonably priced products that replace imported analogues and meet the domestic needs of the Russian market."